132 related articles for article (PubMed ID: 10379873)
1. Deletion mapping at 12p12-13 in metastatic prostate cancer.
Kibel AS; Freije D; Isaacs WB; Bova GS
Genes Chromosomes Cancer; 1999 Jul; 25(3):270-6. PubMed ID: 10379873
[TBL] [Abstract][Full Text] [Related]
2. Identification of 12p as a region of frequent deletion in advanced prostate cancer.
Kibel AS; Schutte M; Kern SE; Isaacs WB; Bova GS
Cancer Res; 1998 Dec; 58(24):5652-5. PubMed ID: 9865716
[TBL] [Abstract][Full Text] [Related]
3. A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p).
Baens M; Wlodarska I; Corveleyn A; Hoornaert I; Hagemeijer A; Marynen P
Genomics; 1999 Feb; 56(1):40-50. PubMed ID: 10036184
[TBL] [Abstract][Full Text] [Related]
4. An 800-kb region of deletion at 13q14 in human prostate and other carcinomas.
Chen C; Frierson HF; Haggerty PF; Theodorescu D; Gregory CW; Dong JT
Genomics; 2001 Oct; 77(3):135-44. PubMed ID: 11597138
[TBL] [Abstract][Full Text] [Related]
5. A common deletion at chromosomal region 17q21 in sporadic prostate tumors distal to BRCA1.
Dai Q; Deubler DA; Maxwell TM; Zhu XL; Cui J; Rohr LR; Stephenson RA; Brothman AR
Genomics; 2001 Feb; 71(3):324-9. PubMed ID: 11170749
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity at 12P12-13 in primary and metastatic prostate adenocarcinoma.
Kibel AS; Faith DA; Bova GS; Isaacs WB
J Urol; 2000 Jul; 164(1):192-6. PubMed ID: 10840458
[TBL] [Abstract][Full Text] [Related]
7. Xq27-28 deletions in prostate carcinoma.
Kibel AS; Faith DA; Bova GS; Isaacs WB
Genes Chromosomes Cancer; 2003 Aug; 37(4):381-8. PubMed ID: 12800149
[TBL] [Abstract][Full Text] [Related]
8. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.
Paige AJ; Taylor KJ; Stewart A; Sgouros JG; Gabra H; Sellar GC; Smyth JF; Porteous DJ; Watson JE
Cancer Res; 2000 Mar; 60(6):1690-7. PubMed ID: 10749141
[TBL] [Abstract][Full Text] [Related]
9. Defining a common region of deletion at 13q21 in human cancers.
Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
[TBL] [Abstract][Full Text] [Related]
10. Physical mapping of chromosome 8p22 markers and their homozygous deletion in a metastatic prostate cancer.
Bova GS; MacGrogan D; Levy A; Pin SS; Bookstein R; Isaacs WB
Genomics; 1996 Jul; 35(1):46-54. PubMed ID: 8661103
[TBL] [Abstract][Full Text] [Related]
11. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
[TBL] [Abstract][Full Text] [Related]
12. Functional evidence for a metastasis suppressor gene for rat prostate cancer within a 60-kilobase region on human chromosome 8p21-p12.
Nihei N; Kouprina N; Larionov V; Oshima J; Martin GM; Ichikawa T; Barrett JC
Cancer Res; 2002 Jan; 62(2):367-70. PubMed ID: 11809681
[TBL] [Abstract][Full Text] [Related]
13. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
14. Molecular mapping of chromosome 2 deletions in murine radiation-induced AML localizes a putative tumor suppressor gene to a 1.0 cM region homologous to human chromosome segment 11p11-12.
Silver A; Moody J; Dunford R; Clark D; Ganz S; Bulman R; Bouffler S; Finnon P; Meijne E; Huiskamp R; Cox R
Genes Chromosomes Cancer; 1999 Feb; 24(2):95-104. PubMed ID: 9885975
[TBL] [Abstract][Full Text] [Related]
15. Identification of tumor metastasis suppressor region on the short arm of human chromosome 20.
Goodarzi G; Mashimo T; Watabe M; Cuthbert AP; Newbold RF; Pai SK; Hirota S; Hosobe S; Miura K; Bandyopadhyay S; Gross SC; Balaji KC; Watabe K
Genes Chromosomes Cancer; 2001 Sep; 32(1):33-42. PubMed ID: 11477659
[TBL] [Abstract][Full Text] [Related]
16. Homozygous and frequent deletion of proximal 8p sequences in human prostate cancers: identification of a potential tumor suppressor gene site.
Prasad MA; Trybus TM; Wojno KJ; Macoska JA
Genes Chromosomes Cancer; 1998 Nov; 23(3):255-62. PubMed ID: 9790507
[TBL] [Abstract][Full Text] [Related]
17. Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH).
Cher ML; Ito T; Weidner N; Carroll PR; Jensen RH
J Urol; 1995 Jan; 153(1):249-54. PubMed ID: 7966782
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of ETV6 in prostate carcinoma.
Kibel AS; Faith DA; Bova GS; Isaacs WB
Prostate; 2002 Sep; 52(4):305-10. PubMed ID: 12210491
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms.
Steinemann D; Gesk S; Zhang Y; Harder L; Pilarsky C; Hinzmann B; Martin-Subero JI; Calasanz MJ; Mungall A; Rosenthal A; Siebert R; Schlegelberger B
Genes Chromosomes Cancer; 2003 Aug; 37(4):421-6. PubMed ID: 12800155
[TBL] [Abstract][Full Text] [Related]
20. Identification and mapping of novel tumor suppressor loci on 6p in diffuse large B-cell non-Hodgkin's lymphoma.
Nagai H; Kinoshita T; Suzuki H; Hatano S; Murate T; Saito H
Genes Chromosomes Cancer; 1999 Jul; 25(3):277-83. PubMed ID: 10379874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
